Lumiseek: The Cancer Impact Network Podcast

Our first guest is Brian Culley, CEO of Lineage Cell Therapeutics.  Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs such as dry AMD and patients with acute spinal cord injuries. Brian Culley discusses Lineage’s clinical programs in dry-AMD, spinal cord injury and cancer, markets with billion dollar opportunities. For more information visit https://lineagecell.com/